New Covid Subvariants

Symptoms of an Infection with BQ.1 and BQ.1.1

Symptoms of an Infection with BQ.1 and BQ.1.1 The subvariants BQ.1 and BQ.1.1 account for nearly 70 percent of cases in the U.S. in December 2022, according to the Centers for Disease Control and Prevention. People infected with these subvariants also tend to report cold-like symptoms: sore throats headaches runny noses fever and night sweats…

COVID-19 Vaccination

New Vaccine Reports, Variants & Guidelines

New Vaccine Reports, Variants & Guidelines In the government’s first assessment of how the shots have been working beyond Pfizer and Moderna’s initial experiments, the Moderna and Pfizer-BioNTech vaccines are about 90% effective at preventing COVID-19 disease, especially severe illness and death. 100% Efficacy in Vaccine Trial for Adolescents Results from Pfizer/BioNTech’s Covid-19 clinical trial…